Sporotrichosis is the most common subcutaneous mycosis in South America and its association with zoonotic transmission remains a relevant public health problem in Rio de Janeiro, Brazil. The disease most commonly presents as subacute or chronic cutaneous lesions, although dissemination to various organs and systems occurs in rare cases, mainly in immunosuppressed individuals. This report describes a case of sporotrichosis with severe bone and subcutaneous damage in an immunocompetent patient who did not exhibit the characteristic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis.
INTRODUCTION
Sporotrichosis is a subacute or chronic infection caused by one of the six putative phylogenetic species of the Sporothrix schenckii complex (1) , a thermally dimorphic fungus that is commonly found on decaying plants and in the soil (2) . The disease occurs worldwide, although it is more common in tropical and subtropical areas with warm (15-25 o C) and humid (90%) climates. Sporotrichosis is the most common subcutaneous mycosis in South America and has been reported in Brazil since 1907 (3) , where epidemics have been related to close contact with infected cats (4) . The disease is initiated when the fungus enters a minor skin injury or, rarely, when the spores of the fungus are inhaled (5) . A rare case of osteoarticular sporotrichosis in an immunocompetent patient is presented herein.
CASE REPORT
A 35-year-old black man, who was born and residing in the neighborhood of Riachuelo in Rio de Janeiro (Brazil), presented for care in July 2014.
At the fi rst clinical appointment, the patient reported that a year previously he had presented with a painful edema in the dorsum of the right foot associated with progressive swelling, which had evolved to spontaneous drainage of secretions a few weeks later. The patient denied any previous skin lesions. Over the following months, the pretibial region (6-8cm in length) and right ankle had become edematous and showed spontaneous discharge ( Figures 1A and 1B) . Notably, the patient did not exhibit the classic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis. The patient reported a 10kg weight loss over the preceding year, and a daily fever for the prior 6 months.
A healthy cat had lived in the patient's house until its death 3 years previously, although this cat had never presented with any skin injuries.
Magnetic resonance imaging (SIEMENS Avanto 1,5T MR system) showed osteomyelitis with severe damage to the right tibia (Figures 2A and 2B ) and talus ( Figure 2C ). Bone fi stulas in the adjacent tissue were also detected (Figure 2A and 2B) . Treatment with 400mg once daily itraconazole was initiated in July 2014, and, after 7 months of therapy, the fi stulas and edema were totally regressed. However, the bone damage remained ( Figure 3A, 3B and 3C) , and the patient continued treatment with Itraconazole.
Ethical considerations
The patient was informed and agreed with the report.
DISCUSSION
The most frequent presentation of sporotrichosis is either a subacute or a chronic, ulcerated and/or verrucous, erythematous nodule at the site of entry of the fungus into the A B C skin, with or without local lymphatic spread (4) . The dissemination to viscera or osteoarticular structures, although uncommon, has been described and is associated with alcohol abuse or immunosuppression, especially in human immunodefi ciency virus (HIV)-infected patients with advanced immunosuppression (6) . Bone and articular involvement are the most common presentations of extracutaneous sporotrichosis (7) , and can occur via direct inoculation of the fungus or through hematogenous dissemination. The most commonly affected bones are the tibia, small bones of the hands, radius, ulna, knee, and ankle (8) .
Notably, this patient showed aggressive clinical progression, with extensive osteoarticular damage, fi stulae, and systemic symptoms, although without the initial cutaneous lesions that characterize sporotrichosis. In addition, the patient was not HIV-positive and did not have any other known reason for immunosuppression. The patient reported no contact with an infected animal.
This article highlights the importance of considering sporotrichosis as a diagnostic possibility in chronic osteomyelitis, even in the absence of skin lesions or a suggestive epidemiological history. It has been suggested that a failure to consider S. schenckii as a potential etiologic agent in these settings may lead to an average delay in diagnosis of 25 months, with eventual progression to dissemination and death (9) . The diagnostic delay in this case is likely responsible for the duration and severity of the damage observed in the bones; however, we cannot eliminate the possibility that the disease was caused by Sporothrix brasiliensis, which is considered the most virulent of the S. schenckii complex, and has been isolated in Rio de Janeiro previously (10) . Other agents, including Mycobacterium species, Actinomyces, Nocardia, and the fungi responsible for the eumycotic mycetomas, are known to cause cutaneous and osteoarticular infections with similar clinical manifestations to those described in this patient, and must be included in the differential diagnosis (11) . It is important to be aware of these possibilities, and to look for the characteristic clear sulfur granules present in the purulent secretions of actinomycosis, and less frequently in nocardiosis, as well as the black or pale grains present in eumycotic mycetomas. Granules can be examined by microscopy to reveal the morphology of the bacteria or fungi present in the lesion, or by culture, which is more accurate in revealing the causative agent, but can take as long as 4 weeks to reveal growth in the case of some fungi (12) (13) . The material should also be cultivated in anaerobic media for isolation of Actinomyces and Nocardia (12) . To confi rm a sporotrichosis diagnosis, serological analyses and direct stains are generally not useful. Culture remains the gold standard and most sensitive method, although one negative culture does not always eliminate the diagnosis. In specifi c settings, particularly when there is joint drainage or when synovial biopsies are not available, repeated samples may be required to prevent diagnosis delay (11) .
Cutaneous and lymphocutaneous sporotrichosis can be treated with a saturated solution of potassium iodide or itraconazole, which is preferable due to its better tolerability and effi cacy. Furthermore, when the infection affects osteoarticular structures, itraconazole is the therapy of choice. However, amphotericin B should be used when the disease is disseminated and associated with immunosuppression (14) . Itraconazole was used in this patient and resulted in total resolution of the fi stulae and edema. However, the maintenance of bone damage demanded longer-term treatment and demonstrated the severe consequences of a delayed diagnosis.
